Browse > Article
http://dx.doi.org/10.5653/cerm.2017.44.4.175

Fertility preservation for patients with gynecologic malignancies: The Korean Society for Fertility Preservation clinical guidelines  

Lee, Sanghoon (Department of Obstetrics and Gynecology, Korea University College of Medicine)
Kim, Seul Ki (Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital)
Hwang, Kyung Joo (Department of Obstetrics and Gynecology, Ajou University School of Medicine)
Kim, Tak (Department of Obstetrics and Gynecology, Korea University College of Medicine)
Kim, Seok Hyun (Department of Obstetrics and Gynecology, Seoul National University College of Medicine)
Publication Information
Clinical and Experimental Reproductive Medicine / v.44, no.4, 2017 , pp. 175-180 More about this Journal
Abstract
Fertility preservation plays a central role in cancer care since an increasingly large number of cancer patients are surviving as a result of improvements in diagnostic and therapeutic strategies. Physicians who take part in the initial diagnosis and management of gynecologic cancer should understand the importance of fertility preservation. Since indications for fertility preservation are limited to early-stage gynecologic cancer, a surgeon must carefully consider each indication. Before performing fertility-sparing surgery, health professionals should compare its oncologic and pregnancy outcomes with those of other standard treatments. Individualized treatment strategies should be delivered depending on the patient's situation, and physicians should provide timely information and appropriate counseling.
Keywords
Fertility preservation; Fertility-sparing surgery; Gynecologic cancer; Pregnancy;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24:2917-31.   DOI
2 National Comprehensive Cancer Network. Adolescent and Young Adult (AYA) Oncology version 2.2017: NCCN clinical practice guidelines in oncology (NCCN guidelines) [Internet]. Fort Washington: National Comprehensive Cancer Network; 2017 [cited 2017 Aug 14]. Available from: https://www.nccn.org/professionals.
3 National Cancer Center. Annual report of cancer statistics in Korea in 2012. Sejong: Ministry of Health and Welfare; 2014.
4 Lee S, Song JY, Ku SY, Kim SH, Kim T. Fertility preservation in women with cancer. Clin Exp Reprod Med 2012;39:46-51.   DOI
5 Hwang JH, Yoo HJ, Park SH, Lim MC, Seo SS, Kang S, et al. Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy. Fertil Steril 2012;97:1387-93.e1-2.   DOI
6 National Comprehensive Cancer Network. Cervical cancer version I.2017: NCCN clinical practice guidelines in oncology (NCCN guidelines) [Internet]. Fort Washington: National Comprehensive Cancer Network; 2016 [cited 2017 Aug 14]. Available from: https://www.nccn.org/professionals.
7 Plante M, Gregoire J, Renaud MC, Roy M. The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies. Gynecol Oncol 2011;121:290-7.   DOI
8 Willows K, Lennox G, Covens A. Fertility-sparing management in cervical cancer: balancing oncologic outcomes with reproductive success. Gynecol Oncol Res Pract 2016;3:9.   DOI
9 Schlaerth AC, Chi DS, Poynor EA, Barakat RR, Brown CL. Longterm survival after fertility-sparing surgery for epithelial ovarian cancer. Int J Gynecol Cancer 2009;19:1199-204.   DOI
10 Kajiyama H, Shibata K, Mizuno M, Nawa A, Mizuno K, Matsuzawa K, et al. Fertility-sparing surgery in young women with mucinous adenocarcinoma of the ovary. Gynecol Oncol 2011;122:334-8.   DOI
11 Ditto A, Martinelli F, Lorusso D, Haeusler E, Carcangiu M, Raspagliesi F. Fertility sparing surgery in early stage epithelial ovarian cancer. J Gynecol Oncol 2014;25:320-7.   DOI
12 National Comprehensive Cancer Network. Ovarian cancer including fallopian tube cancer and primary peritoneal cancer version I 2016: NCCN clinical practice guidelines in oncology (NCCN guidelines) [Internet]. Fort Washington: National Comprehensive Cancer Network; 2016 [cited 2017 Aug 14]. Available from: https://www.nccn.org/professionals.
13 Satoh T, Hatae M, Watanabe Y, Yaegashi N, Ishiko O, Kodama S, et al. Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J Clin Oncol 2010;28:1727-32.   DOI
14 Fruscio R, Ceppi L, Corso S, Galli F, Dell'Anna T, Dell'Orto F, et al. Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer. Br J Cancer 2016;115:641-8.   DOI
15 Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, et al. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol 2008;110:345-53.   DOI
16 Lee SW, Lee TS, Hong DG, No JH, Park DC, Bae JM, et al. Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement. J Gynecol Oncol 2017;28:e12.   DOI
17 Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.   DOI
18 Shepherd JH, Spencer C, Herod J, Ind TE. Radical vaginal trachelectomy as a fertility-sparing procedure in women with earlystage cervical cancer-cumulative pregnancy rate in a series of 123 women. BJOG 2006;113:719-24.   DOI
19 Hertel H, Kohler C, Grund D, Hillemanns P, Possover M, Michels W, et al. Radical vaginal trachelectomy (RVT) combined with laparoscopic pelvic lymphadenectomy: prospective multicenter study of 100 patients with early cervical cancer. Gynecol Oncol 2006;103:506-11.   DOI
20 Mathevet P, Laszlo de Kaszon E, Dargent D. Fertility preservation in early cervical cancer. Gynecol Obstet Fertil 2003;31:706-12.   DOI
21 Wang D, Yang J, Shen K, Xiang Y. Neoadjuvant chemotherapy followed by fertility-sparing surgery for women with stage IB1 cervical cancer. J Gynecol Oncol 2013;24:287-90.   DOI
22 Bentivegna E, Gouy S, Maulard A, Chargari C, Leary A, Morice P. Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review. Lancet Oncol 2016;17:e240-53.   DOI
23 Bentivegna E, Maulard A, Pautier P, Chargari C, Gouy S, Morice P. Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature. Fertil Steril 2016;106:1195-211.e5.   DOI
24 Vasconcelos I, de Sousa Mendes M. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk. Eur J Cancer 2015;51:620-31.   DOI
25 Lass A. The fertility potential of women with a single ovary. Hum Reprod Update 1999;5:546-50.   DOI
26 Korean Society of Gynecologic Oncology. Practice guideline for ovarian cancer version 3.0 [Internet]. Seoul: Korean Society of Gynecologic Oncology; 2015 [cited 2017 Aug 14]. Available from: http://www.sgo.or.kr.
27 Crissman JD, Azoury RS, Barnes AE, Schellhas HF. Endometrial carcinoma in women 40 years of age or younger. Obstet Gynecol 1981;57:699-704.
28 Park JY, Nam JH. Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer. Oncologist 2015;20:270-8.   DOI
29 Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 1984;64:417-20.
30 Korean Society of Gynecologic Oncology. Practice guideline for uterine corpus cancer version 3.0 [Internet]. Seoul: Korean Society of Gynecologic Oncology; 2015 [cited 2017 Aug 14]. Available from: http://www.sgo.or.kr.
31 National Comprehensive Cancer Network. Uterine neoplasms version I.2017: NCCN clinical practice guidelines in oncology (NCCN guidelines) [Internet]. Fort Washington: National Comprehensive Cancer Network; 2016 [cited 2017 Aug 14]. Available from: https://www.nccn.org/professionals.
32 Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol 2004;95:133-8.   DOI
33 Tangjitgamol S, Manusirivithaya S, Hanprasertpong J. Fertilitysparing in endometrial cancer. Gynecol Obstet Invest 2009;67:250-68.   DOI
34 Erkanli S, Ayhan A. Fertility-sparing therapy in young women with endometrial cancer: 2010 update. Int J Gynecol Cancer 2010;20:1170-87.   DOI
35 SGO Clinical Practice Endometrial Cancer Working Group, Burke WM, Orr J, Leitao M, Salom E, Gehrig P, et al. Endometrial cancer: a review and current management strategies. Part II. Gynecol Oncol 2014;134:393-402.   DOI
36 Sun C, Chen G, Yang Z, Jiang J, Yang X, Li N, et al. Safety of ovarian preservation in young patients with early-stage endometrial cancer: a retrospective study and meta-analysis. Fertil Steril 2013;100:782-7.   DOI
37 Wright JD, Buck AM, Shah M, Burke WM, Schiff PB, Herzog TJ. Safety of ovarian preservation in premenopausal women with endometrial cancer. J Clin Oncol 2009;27:1214-9.   DOI
38 Gallos ID, Yap J, Rajkhowa M, Luesley DM, Coomarasamy A, Gupta JK. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol 2012;207:266.e1-12.